Intuitive Surgical (ISRG, Health Care Equipment) Stock Valuation & Fair Value Significantly overvalued
Intuitive Surgical (ISRG, Health Care Equipment) trades at a blended P/E of 39.1, about 17% below its historical normal valuation, with a forward growth estimate of 13.1% and a PEG of 2.99. Analysts' one-year estimates have been hit 27% of the time.
The Street vs SeerForecast
Wall Street's mean price target for ISRG is $478.01 across 30 analysts, 26.2% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: significantly overvalued. When the two disagree, start your digging there.
Valuation flags
- No notable valuation flags.
Verdict history
tickerseer's rating has been significantly overvalued since 2026-06-03.
Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.
Frequently asked questions
Is Intuitive Surgical stock overvalued?
At a blended P/E of 39.1 versus its historical normal P/E of 47.0, Intuitive Surgical trades about 17% below its typical valuation, with a PEG of 2.99 on 13.1% forward growth. tickerseer currently rates it significantly overvalued.
What is Intuitive Surgical's fair value and PEG?
Intuitive Surgical trades at a blended P/E of 39.1 against a historical normal P/E of 47.0, a PEG of 2.99, and a forward growth estimate of 13.1%.
Has tickerseer's rating of Intuitive Surgical changed?
tickerseer's rating has been significantly overvalued since 2026-06-03.
What is the analyst price target for Intuitive Surgical?
The mean Wall Street price target for Intuitive Surgical is $478.01 across 30 analysts, 26.2% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.
Industry: Health Care Equipment. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. Educational content, not investment advice.